Stimufol 2.5 mg Tablet

Stimufol 2.5 mg Tablet contains letrozole 2.5 mg, an oral aromatase inhibitor used in cancer treatment. It is mainly used for hormone-sensitive breast cancer, particularly in postmenopausal women. The tablet is a prescription medicine and should be taken under specialist medical supervision.

BUY NOW

Letrozole works by reducing estrogen production in the body, which can slow the growth of hormone-dependent breast cancer cells. It may be prescribed after initial breast cancer treatment or for advanced disease according to the patient’s treatment plan. Regular monitoring may include bone health and cholesterol levels because long-term estrogen reduction can affect bone density and lipid levels. The dose and duration are determined by the treating specialist based on the cancer type, treatment stage, and individual response.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 5 tablets
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Stimufol 2.5mg Tablet, Stimufol 2.5 mg Tablet, Stimufol 2.5 Tablet, Letrozole 2.5mg Tablet, Letrozole 2.5 mg Tablet, Letrozole Oral Tablet, Letrozole Breast Cancer Tablet